News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News SCAI Releases Practical, Technical Advice for Primary PCI in STEMI Michael O'Riordan October 10, 2024
News Daily News Different Guidelines for Acute PE Offer a Mixed Bag of Advice Caitlin E. Cox October 08, 2024
News Daily News ‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making Yael L. Maxwell August 14, 2024
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024
News Daily News Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI Michael O'Riordan March 26, 2024
News Daily News Statin Use Has Plateaued in US Primary Prevention Patients Michael O'Riordan December 05, 2023
News Daily News New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO Todd Neale November 30, 2023
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023
News Daily News Pooled Cohort Equations Work in Real-world Patients, Even Outliers Yael L. Maxwell October 12, 2023
News Daily News Longer-Term ASCVD Risk Assessment Best for Younger Patients Michael O'Riordan February 16, 2023
News Daily News Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short Shelley Wood January 31, 2023
News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Daily News Experts Fear Coronary CT Advice for Patients Misses the Mark Michael O'Riordan March 19, 2021
News Daily News ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care L.A. McKeown January 11, 2021
News Daily News CAC Testing Improves Pretest Probability of Obstructive CAD Michael O'Riordan November 23, 2020